Olokizumab (anti-IL-6)
规格
| Cas Number | 1007223-17-7 |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA |
| 级别 | 无动物源,无载体,重组,ExactAb™,低内毒素,无叠氮钠,已验证 |
| 纯度 | ≥95%(SDS-PAGE&SEC-HPLC) |
| 包装 | 10mg 或 1mg 或 5mg 或 100μg |
产品信息
| 别名 | 抗白介素-6抗体; 奥洛组单抗; Anti-IL-6 / IFNb2 Reference Antibody (olokizumab) ; Interleukin BSF 2 antibody; B cell differentiation factor antibody; B cell stimulatory factor 2 antibody; B-cell stimulatory factor 2 antibody; BSF 2 antibody; BSF-2 antibody; BSF2 antibody; CDF antibody; CTL differentiation factor antibody; Cytotoxic T cell differentiation factor antibody; Hepatocyte stimulating factor antibody; Hepatocyte stimulatory factor antibody; HGF antibody; HSF antibody; Hybridoma growth factor antibody; Hybridoma growth factor Interferon beta-2 antibody; Hybridoma plasmacytoma growth factor antibody; IFN-beta-2 antibody; IFNB2 antibody; IL 6 antibody; IL-6 antibody; IL6 antibody; IL6_HUMAN antibody; Interferon beta 2 antibody; Interferon beta-2 antibody; Interleukin 6 antibody; Interleukin 6 (interferon beta 2) antibody; Interleukin BSF 2 antibody; Interleukin-6 antibody; B-cell differentiation factor; B-cell stimulatory factor 2; BSF2; BSF-2; CDF; CTL differentiation factor ; HSF; hybridoma growth factor; IFNB2; IFN-beta-2; IL6; IL-6; Interferon beta-2; interleukin 6 (interferon, beta 2); interleukin BSF-2; interleukin-6; MGI-2A |
| 品牌 | 阿拉丁 |
| 浓度 | 见COA |
| Action Type | 抑制剂 |
| Mechanism Of Action | 白细胞介素 6 抑制剂 |
| Application | ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR) |
| 简短描述 | Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated |
| 英文简短描述 | Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated |
| 稳定性和储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| 轻链类型 | kappa |
| 过滤标签 | Gene ID:3569,Accession#:P05231,IL6 |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| Clonality | 重组抗体 |
| 形式 | Whole IgG |
| Accession ID | P05231 |
| 物理形态 | 液体 |
| 特异性 | IL6 |
| Species reactivity（Reacts with) | 人(Human),食蟹猴(Cynomolgus monkey),恒河猴(Rhesus monkey) |
| Conjugate | Unconjugated |
| 纯化方法 | Protein A purified |
| 储存缓冲液 | Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0 |
| 亚型 | Human IgG1 |
| Host species | 人(Human) |
| 靶标动物 | Human, Rhesus Macaque, Cynomolgus |
| 内毒素浓度 | <1.0 EU/mg |
| Source | CHO细胞培养上清 |
| 描述 |
Olokizumab (anti-IL-6) 是一种靶向白细胞介素-6（IL-6）的人源化单克隆抗体。奥洛组单抗可用于类风湿性关节炎（RA）的研究。 |
| 英文描述 |
Olokizumab (anti-IL-6) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA). |
| SDS-PAGE | 26.1 kDa (Light Chain) & 50.7 kDa (Heavy Chain), under reducing conditions; 167.7 kDa, under non-reducing conditions. |